These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 34654614)

  • 1. Fat intake pattern in women with polycystic ovary syndrome.
    Navarro-Lafuente F; Arense-Gonzalo JJ; Sánchez-Ferrer ML; Prieto-Sánchez MT; Cutillas-Tolín A; Mendiola J; Adoamnei E; Gazabat-Barbado E; Vioque J; Torres-Cantero AM
    Reprod Biomed Online; 2022 Jan; 44(1):93-103. PubMed ID: 34654614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are Dietary Indices Associated with Polycystic Ovary Syndrome and Its Phenotypes? A Preliminary Study.
    Cutillas-Tolín A; Arense-Gonzalo JJ; Mendiola J; Adoamnei E; Navarro-Lafuente F; Sánchez-Ferrer ML; Prieto-Sánchez MT; Carmona-Barnosi A; Vioque J; Torres-Cantero AM
    Nutrients; 2021 Jan; 13(2):. PubMed ID: 33499268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Prevalence of Polycystic Ovary Syndrome, Its Phenotypes and Cardio-Metabolic Features in a Community Sample of Iranian Population: Tehran Lipid and Glucose Study.
    Farhadi-Azar M; Behboudi-Gandevani S; Rahmati M; Mahboobifard F; Khalili Pouya E; Ramezani Tehrani F; Azizi F
    Front Endocrinol (Lausanne); 2022; 13():825528. PubMed ID: 35299965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A genetic risk score is associated with polycystic ovary syndrome-related traits.
    Lee H; Oh JY; Sung YA; Chung HW
    Hum Reprod; 2016 Jan; 31(1):209-15. PubMed ID: 26573528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of clinical and hormonal characteristics among four phenotypes of polycystic ovary syndrome based on the Rotterdam criteria.
    Jamil AS; Alalaf SK; Al-Tawil NG; Al-Shawaf T
    Arch Gynecol Obstet; 2016 Feb; 293(2):447-56. PubMed ID: 26408006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are there differences in basal thrombophilias and C-reactive protein between women with or without PCOS?
    Sánchez-Ferrer ML; Prieto-Sánchez MT; Corbalán-Biyang S; Mendiola J; Adoamnei E; Hernández-Peñalver AI; Carmona-Barnosi A; Salido-Fiérrez EJ; Torres-Cantero AM
    Reprod Biomed Online; 2019 Jun; 38(6):1018-1026. PubMed ID: 31023609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Association between dietary fat intake and risk of polycystic ovary syndrome].
    Zhang X; Wang C; Cheng J; Wu X; Wang J; Luo G
    Wei Sheng Yan Jiu; 2024 May; 53(3):389-395. PubMed ID: 38839593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary glycemic index is associated with less favorable anthropometric and metabolic profiles in polycystic ovary syndrome women with different phenotypes.
    Graff SK; Mário FM; Alves BC; Spritzer PM
    Fertil Steril; 2013 Oct; 100(4):1081-8. PubMed ID: 23830153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of the newly recommended antral follicle count cutoff for polycystic ovary in adult women with polycystic ovary syndrome.
    Kim JJ; Hwang KR; Chae SJ; Yoon SH; Choi YM
    Hum Reprod; 2020 Mar; 35(3):652-659. PubMed ID: 32211797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of different phenotypes of polycystic ovary syndrome based on the Rotterdam criteria in a large-scale Chinese population.
    Zhang HY; Zhu FF; Xiong J; Shi XB; Fu SX
    BJOG; 2009 Nov; 116(12):1633-9. PubMed ID: 19781047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
    Hassa H; Tanir HM; Yildiz Z
    Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone.
    Lauritsen MP; Bentzen JG; Pinborg A; Loft A; Forman JL; Thuesen LL; Cohen A; Hougaard DM; Nyboe Andersen A
    Hum Reprod; 2014 Apr; 29(4):791-801. PubMed ID: 24435776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using cluster analysis to identify a homogeneous subpopulation of women with polycystic ovarian morphology in a population of non-hyperandrogenic women with regular menstrual cycles.
    Dewailly D; Alebić MŠ; Duhamel A; Stojanović N
    Hum Reprod; 2014 Nov; 29(11):2536-43. PubMed ID: 25267785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adolescents diagnosed with polycystic ovary syndrome under the Rotterdam criteria but not meeting the diagnosis under the updated guideline.
    Kim JJ; Hwang KR; Lee D; Kim S; Choi YM
    Hum Reprod; 2024 May; 39(5):1072-1077. PubMed ID: 38514450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between Coffee Consumption and Polycystic Ovary Syndrome: An Exploratory Case-Control Study.
    Meliani-Rodríguez A; Cutillas-Tolín A; Mendiola J; Sánchez-Ferrer ML; De la Cruz-Sánchez E; Vioque J; Torres-Cantero AM
    Nutrients; 2024 Jul; 16(14):. PubMed ID: 39064680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Hidden Link between Polycystic Ovary Syndrome and Kidney Stones: Finding from the Tehran Lipid and Glucose Study (TLGS).
    Rostami Dovom M; Rahmati M; Amanollahi Soudmand S; Ziaeefar P; Azizi F; Ramezani Tehrani F
    Diagnostics (Basel); 2023 Aug; 13(17):. PubMed ID: 37685351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Updated ultrasound criteria for polycystic ovary syndrome: reliable thresholds for elevated follicle population and ovarian volume.
    Lujan ME; Jarrett BY; Brooks ED; Reines JK; Peppin AK; Muhn N; Haider E; Pierson RA; Chizen DR
    Hum Reprod; 2013 May; 28(5):1361-8. PubMed ID: 23503943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-polycystic ovary syndrome and polymenorrhoea as new facets of polycystic ovary syndrome (PCOS): Evidences from a single centre data set.
    Ganie MA; Rashid A; Baba MS; Zargar MA; Wani IA; Nisar S; Wani IA; Douhath S; Sriwastawa M; Geer MI; Asrar MM; Kutum R; Hassan S; Khan S; Rafi W; Bhat DA; Showkat W; Sahar T; Choh NA; Khurshid R; Mudassar S; Shah ZA; Shabir I; Sofi SA; Gupta N; Hafeez I; Sreenivas V
    Clin Endocrinol (Oxf); 2023 Dec; 99(6):566-578. PubMed ID: 37656656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of the serum anti-Müllerian hormone assay as a surrogate for polycystic ovarian morphology: impact on diagnosis and phenotypic classification of polycystic ovary syndrome.
    Fraissinet A; Robin G; Pigny P; Lefebvre T; Catteau-Jonard S; Dewailly D
    Hum Reprod; 2017 Aug; 32(8):1716-1722. PubMed ID: 28854589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature.
    Azziz R
    J Clin Endocrinol Metab; 2006 Mar; 91(3):781-5. PubMed ID: 16418211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.